Staff reportsStephenson Cancer Center at OU Medicine recently launched a clinical trial testing an immunotherapy drug for men who are on active surveillance.Men who are diagnosed with low-risk prostate cancer usually opt for active surveillance — a monitoring of their cancer over time without undergoing treatments that would cause side effects.Read more on NewsOK.com